News

The US Court of Appeals for the Federal Circuit has upheld the earlier district court's decision that a proposed generic equivalent from Teva Pharmaceutical Industries would infringe on

Merck paid $230m upfront for two clinical-stage DNA damage and repair candidates and two additional preclinical programs, of which the company will take full responsibility in development and commercialization. US-based

This global Phase 2a clinical trial is being conducted in approximately 150 ambulatory patients diagnosed with influenza A. Patients in the Phase 2a clinical trial will be randomized

The marketing authorization allows for the marketing of TAF in the 28 countries of the European Union, Norway and Iceland. University of Milan Fondazione IRCCS Ca’ Granda Ospedale

Orphan drug designations are granted to drugs and biologics intended to treat rare diseases. The designation provides incentives to advance development of rare disease drugs and for commercialization

The therapeutic compound was studied for its safety and tolerability and was found to have stabilized the disease on CT imaging in a majority of patients in the

This multi-center, randomized, double-blind study was designed to compare the efficacy, safety and tolerability of intravenous and oral Debio 1450 at two dose regimens with intravenous vancomycin /

These projects will be conducted by leading academic institutions, non-profit organizations and community groups from around the world, focusing on three key areas: translational research, efficacy studies in

This is the first application for regulatory approval of KEYTRUDA in combination with another treatment. The FDA granted Priority Review with a PDUFA, or target action, date of